Field efficacy of fluralaner (Bravecto chewable tablets) for preventing Babesia canis infection transmitted by Dermacentor reticulatus ticks to dogs.

Background: The isoxazoline fluralaner is effective for prevention of Babesia canis transmission from infected Dermacentor reticulatus ticks to dogs for 84 days in a controlled environment. This study was designed to evaluate the effectiveness of fluralaner chewable tablets for sustained prevention of B. canis infection of dogs in endemic areas under natural conditions.